Your browser doesn't support javascript.
loading
Review of real-time release testing of pharmaceutical tablets: State-of-the art, challenges and future perspective.
Markl, Daniel; Warman, Martin; Dumarey, Melanie; Bergman, Eva-Lotta; Folestad, Staffan; Shi, Zhenqi; Manley, Leo Francis; Goodwin, Daniel J; Zeitler, J Axel.
Afiliação
  • Markl D; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK; EPSRC Centre for Innovative Manufacturing inContinuous Manufacturing and Crystallisation, University of Strathclyde, Glasgow, UK. Electronic address: daniel.markl@strath.ac.uk.
  • Warman M; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK; Martin Warman Consultancy Ltd, 7 Grasmere Road, Chestfield, Kent CT5 3LY, UK.
  • Dumarey M; Pharmaceutical Technology and Development, AstraZeneca, 43150 Mölndal, Sweden.
  • Bergman EL; Pharmaceutical Technology and Development, AstraZeneca, 43150 Mölndal, Sweden.
  • Folestad S; Pharmaceutical Technology and Development, AstraZeneca, 43150 Mölndal, Sweden.
  • Shi Z; Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Manley LF; Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN 46285, USA.
  • Goodwin DJ; GSK Research & Development, Park Road, Ware SG12 0DP, UK.
  • Zeitler JA; Department of Chemical Engineering and Biotechnology, University of Cambridge, Philippa Fawcett Drive, CB3 0AS Cambridge, UK.
Int J Pharm ; 582: 119353, 2020 May 30.
Article em En | MEDLINE | ID: mdl-32325242
ABSTRACT
In the last decade significant advances have been made in process analytical technologies and digital manufacturing of pharmaceutical oral solid dosage forms leading to enhanced product knowledge and process understanding. These developments provide an excellent platform for realising real-time release testing (RTRT) to eliminate all, or certain, off-line end product tests assuring that the drug product is of intended quality. This review article presents the state of the art, an RTRT development workflow as well as challenges and opportunities of RTRT in batch and continuous manufacturing of pharmaceutical tablets. Critical quality attributes, regulatory aspects and the scientific basis of enabling technologies and models for RTRT are discussed and a systematic development workflow for the robust design of an RTRT environment is presented. This includes the discussion of key considerations for the identification of the critical quality attributes and points of testing as well as the development of the sampling strategy, a hard and/or soft sensor approach and operational procedures. The final sections present two RTRT use cases in an industrial setting as well as critically discuss challenges and provide a future perspective of RTRT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Tecnologia Farmacêutica Tipo de estudo: Prognostic_studies Idioma: En Revista: Int J Pharm Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Tecnologia Farmacêutica Tipo de estudo: Prognostic_studies Idioma: En Revista: Int J Pharm Ano de publicação: 2020 Tipo de documento: Article